PIN1 and cancer: It has been shown that Pin1 is overexpressed and/or overactivated in the majority of human cancers including breast, lung, colon, prostate and liver cancers, with its levels being correlated with poor outcomes in cancer patients21, 22, 23, 24, 25, 26.